1
|
Shrivastava A, Jain S, Malhotra P, Mishra S, Pasricha S, Kapoor G. Classical Hodgkin Lymphoma Presenting as Cutaneous and Soft Tissue Mass Lesion: An Enigmatic Presentation Posing a Diagnostic Challenge—A Case Report and Review of Literature. Indian J Med Paediatr Oncol 2022. [DOI: 10.1055/s-0041-1740441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Abstract
AbstractHodgkin lymphoma (HL) is primarily a nodal disease. Cutaneous involvement of HL as a presenting feature is extremely rare. Skin involvement is usually seen as a metachronous involvement in the course of disease and is associated with poor prognosis. Primary skin and soft tissue involvement can be construed as nonhematological, inflammatory, or infective etiology. We report a 14-year-old girl with fever, weight loss, lymphadenopathy, and multiple papular lesions over the right chest wall as initial manifestation of HL, posing a diagnostic challenge. In view of stage IVBE, patient was managed with intensive chemotherapy regimen and is currently free of disease at 6 months of follow-up.
Collapse
Affiliation(s)
- Ayushi Shrivastava
- Department of Pediatric Hematology Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
| | - Sandeep Jain
- Department of Pediatric Hematology Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
| | - Payal Malhotra
- Department of Pediatric Hematology Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
| | - Shalini Mishra
- Department of Pediatric Surgical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
| | - Sunil Pasricha
- Department of Pathology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
| | - Gauri Kapoor
- Department of Pediatric Hematology Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
| |
Collapse
|
2
|
Subtil A, Gru AA. Secondary cutaneous involvement by direct extension in high-grade B-cell lymphomas. J Cutan Pathol 2020; 48:541-546. [PMID: 32639608 DOI: 10.1111/cup.13798] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2020] [Revised: 06/25/2020] [Accepted: 07/01/2020] [Indexed: 11/30/2022]
Abstract
Cutaneous involvement by a systemic lymphoma via direct extension is a very rare phenomenon, historically described in patients who had advanced-stage disease with bulky lymphadenopathy. Since its original description, most cases of cutaneous lymphomatous spread via direct extension are attributable to Hodgkin disease. Here, we report the occurrence of direct cutaneous dissemination in the setting of nodal high-grade B-cell lymphomas, specifically diffuse large B-cell lymphoma (DLBCL) and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma (also called gray-zone lymphoma). Both cases are adequately documented with clinical, histopathologic, and immunophenotypic data, as well as additional cytogenetic analysis.
Collapse
Affiliation(s)
- Antonio Subtil
- Department of Pathology, Royal Jubilee Hospital, Victoria, British Columbia, Canada
| | - Alejandro A Gru
- Departments of Pathology & Dermatology, University of Virginia School of Medicine, Charlottesville, Virginia, USA
| |
Collapse
|
3
|
Macías-García L, Vallejo-Benítez A, Márquez-García A, Marcos-Domínguez Á, Ríos-Martín JJ. Infiltration of abdominal striae distensae by Hodgkin's lymphoma. Int J Dermatol 2018; 57:e82-e83. [PMID: 30020537 DOI: 10.1111/ijd.14151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/19/2018] [Revised: 06/21/2018] [Accepted: 06/22/2018] [Indexed: 11/26/2022]
Affiliation(s)
- Laura Macías-García
- Departament of Cytology and Histology Normal and Pathological, University of Seville, Seville, Spain
| | - Ana Vallejo-Benítez
- Department of Anatomic Pathology, Hospital Universitario Virgen Macarena, Seville, Spain
| | - Ana Márquez-García
- Department of Dermatology, Hospital La Línea de la Concepción, Cádiz, Spain
| | | | - Juan J Ríos-Martín
- Department of Anatomic Pathology, Hospital Universitario Virgen Macarena, Seville, Spain
| |
Collapse
|
4
|
Specific Skin Infiltration as First Sign of Localized Stage Hodgkin's Lymphoma Involving an Epitrochlear Node. Am J Dermatopathol 2015; 37:499-502. [DOI: 10.1097/dad.0000000000000127] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
5
|
Ulas T, Apucu HG, Gulturk E, Karakas EY, Borlu F. Hodgkin's Disease Presenting with Chronic Pruritis and Cutaneous Involvement. J Clin Diagn Res 2015; 9:OL01. [PMID: 25738023 DOI: 10.7860/jcdr/2015/11075.5382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2014] [Accepted: 10/14/2014] [Indexed: 11/24/2022]
Affiliation(s)
- Turgay Ulas
- Associate Professor, Department of Internal Medicine, Harran University, School of Medicine , Sanliurfa
| | - Haci Gokhan Apucu
- Faculty, Department of Internal Medicine, Necip Fazil Metropolitan Training and Research Hospital , Kahramanmaras
| | - Emine Gulturk
- Faculty, Department of Internal Medicine, Sisli Etfal Training and Research Hospital , Istanbul
| | - Emel Yigit Karakas
- Faculty, Department of Internal Medicine, Harran University, School of Medicine , Sanliurfa
| | - Fatih Borlu
- Faculty, Department of Internal Medicine, Sisli Etfal Training and Research Hospital , Istanbul
| |
Collapse
|
6
|
|
7
|
|
8
|
Cho RJ, McCalmont TH, Ai WZ, Fox LP, Treseler P, Pincus LB. Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators. J Cutan Pathol 2012; 39:651-8. [DOI: 10.1111/j.1600-0560.2012.01872.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
9
|
Vieites B, Avila R, Biscuola M, Carvajo F. Cutaneous Hodgkin-type lymphoproliferative lesion associated with immunomodulatory therapy for ulcerative colitis. J Cutan Pathol 2011; 38:443-7. [PMID: 21261674 DOI: 10.1111/j.1600-0560.2010.01663.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Immunomodulatory drugs have demonstrated efficacy in the therapy against autoimmune diseases such as rheumatoid arthritis, Crohn's disease or ulcerative colitis. Tumor necrosis factor-α (TNF-α) represents a target molecule for the treatment of these entities. Use of monoclonal antibodies can block the proinflammatory function of TNF-α. It has been shown that this action can reactivate quiescent chronic diseases as well as modify the immune response or potentiate carcinogens, thereby increasing the risk of secondary tumor development. In this context, different types of solid or hematological tumors have been documented. We present the case of a male with chronic ulcerative colitis who secondarily developed a cutaneous Hodgkin-type lymphoproliferative lesion associated with immunodeficiency. This secondary tumor developed after 6 months of treatment with anti-TNF-α.
Collapse
Affiliation(s)
- Begoña Vieites
- Pathology Department, Virgen del Rocío Universitary Hospital, Seville, Spain
| | | | | | | |
Collapse
|
10
|
Ehst BD, Minzer-Conzetti K, Swerdlin A, Devere TS. Cutaneous manifestations of internal malignancy. Curr Probl Surg 2010; 47:384-445. [PMID: 20363406 DOI: 10.1067/j.cpsurg.2010.01.003] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
11
|
Epstein-Barr Virus–Positive Hodgkin Lymphoma–Like Earlobe Lymphoid Infiltrate: Case Report. Am J Dermatopathol 2009; 31:838-45. [DOI: 10.1097/dad.0b013e3181ac6738] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
12
|
Perifanis V, Sfikas G, Tziomalos K, Sotiriadis D, Garipidou V. Skin Involvement in Hodgkin's Disease. Cancer Invest 2009; 24:401-3. [PMID: 16777693 DOI: 10.1080/07357900600705490] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Hodgkin's disease involving the skin is an unusual occurrence and is found in 0.5-3.4 percent of these patients. The most common clinical presentation is of single or multiple dermal or subcutaneous nodules. The mechanisms usually implicated include direct extension from an underlying nodal focus, hematogenous dissemination, and, most often, retrograde lymphatic spread, distal to involved lymph nodes. We report the case of a patient with refractory Hodgkin's disease who presented with skin involvement.
Collapse
Affiliation(s)
- Vassilios Perifanis
- Haematology Section, 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece
| | | | | | | | | |
Collapse
|
13
|
Bogdanović G, Jakimov D, Stojiljkovic B, Jurisić V. The cell growth, morphology and immunocytochemistry of novel cell line established from a bone marrow of the patient with therapy-related myelodysplastic syndrome, entitled PC-MDS. Med Oncol 2007; 24:419-24. [PMID: 17917092 DOI: 10.1007/s12032-007-0031-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2007] [Revised: 11/30/1999] [Accepted: 05/01/2007] [Indexed: 11/30/2022]
Abstract
We report on cell growth, morphology, and immunocytochemistry of the first human cell line, PC-MDS, derived from a bone marrow of a patient with therapy-related myelodysplastic syndrome who had no overt leukemia post-MDS phase. This cell population consisted of fast-growing mononuclear cells. Standard cytochemistry methods for detection of MPO, lipids, glycogen and ANAE gave results as follows: MPO and SBB negative while PAS and ANAE positive. Positive cytochemical staining and immunophenotype analyses indicated that PC-MDS cells have some characteristics of the early myeloid precursor cell. As the first t-MDS derived cell line it could be a new tool in evaluation of complex biology of MDS and also serves as a model for diverse in-vitro research.
Collapse
|
14
|
Mao X, Orchard G, Russell-Jones R, Whittaker S. Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas. Br J Dermatol 2007; 157:914-21. [PMID: 17725669 DOI: 10.1111/j.1365-2133.2007.08150.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
BACKGROUND CD30+ cutaneous large-cell lymphomas (CLCL) represent a heterogeneous subgroup of skin lymphomas including primary cutaneous CD30+ anaplastic large-cell lymphoma (C-ALCL), lymphomatoid papulosis (LyP), transformed mycosis fungoides (T-MF) and Hodgkin's lymphoma (HL) with cutaneous involvement. The activator protein 1 (AP-1) transcription factor consists of JUN, FOS and other protein families. Recent studies have revealed upregulation of JUNB in both MF and C-ALCL and overexpression of JUNB and CD30 in systemic HL and ALCL. OBJECTIVES To assess systematically the expression pattern of AP-1 transcription factors in CLCL. METHODS We analysed paraffin tissue sections from 27 patients with LyP, 10 with C-ALCL, eight with T-MF and two with cutaneous HL by immunohistochemistry with antibodies against c-JUN, JUNB, JUND, c-FOS and RAF-1. We also stained samples from 10 patients with C-ALCL, seven with Sézary syndrome (SS), six with T-MF, three with cutaneous HL, two with LyP and control samples with total and phosphorylated mitogen-activated protein kinase (MAPK) antibodies. Results Positive staining for JUND (++) was observed in 13 cases of LyP (48%), 10 C-ALCL, six T-MF (75%) and two cutaneous HL cases. Positive JUNB protein expression was present in four cases of T-MF (50%), four C-ALCL (44%), three LyP (11%) and two cutaneous HL. Expression of total (p44/42) MAP kinase and phosphorylated p44/42 MAP kinase were detected in nine cases of C-ALCL (90%), seven SS (88%), five T-MF (89%) and three cutaneous HL. Most of these samples also showed positive staining for JUNB. CONCLUSION These results suggest the presence of abnormal AP-1 protein expression in CLCL, which may be relevant to CLCL.
Collapse
Affiliation(s)
- X Mao
- Skin Tumour Unit, St John's Institute of Dermatology, St Thomas' Hospital, King's College London, UK.
| | | | | | | |
Collapse
|
15
|
Bogdanović G, Jurisić V, Kraguljac N, Mrdjanović J, Jakimov D, Krtolica K, Krajnović M, Magić Z, Stojiljković B, Andrijević L, Srdić T, Baltić M, Popović S. Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndrome. Leuk Res 2007; 31:1097-1105. [PMID: 17350682 DOI: 10.1016/j.leukres.2007.01.012] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2006] [Revised: 12/28/2006] [Accepted: 01/05/2007] [Indexed: 11/17/2022]
Abstract
We report on characteristics of the first human cell line, PC-MDS, derived from a bone marrow of a patient with therapy-related myelodysplastic syndrome (t-MDS) who had no overt post-MDS leukemia. Classic cytology analyses, immunophenotyping, cytogenetic and molecular genetic procedures were used for characterization of the cell line. PC-MDS cells are positive for the expression of CD13, CD15, CD30, CD33, and CD45 antigen. Positive cytochemical staining and immunophenotype analyses indicated that PC-MDS cells have some characteristics of the early myeloid precursor cell. The karyotype analysis of PC-MDS cell line revealed various numerical and structural changes including those typically associated with t-MDS: del(5)(q13)[7], der(5)t(5;11)(p11;q11)[13], -7[6], del(7)(q31)[2], +20[3], -20[4]. Evaluation of methylation status in a promoter region of p15, p16 and MGMT genes showed biallelic hypermethylation pattern of 5' promoter region only in MGMT gene. PC-MDS is the first t-MDS derived cell line, and based on its immunological, cytogenetic and molecular characterization could be a new tool in evaluation of complex biology of MDS and a model for methylation studies.
Collapse
Affiliation(s)
- Gordana Bogdanović
- Institute of Oncology Sremska Kamenica, Institutski put 4, Sremska Kamenica, Serbia.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|